Table of Contents
NACDS President and CEO Steven C. Anderson engages in a discussion at the White House on the implementation and communication of the Inflation Reduction Act with HHS Secretary Xavier Becerra (head of table – left) and Centers for Medicare & Medicaid Services Administrator Chiquita Brooks-LaSure (head of table – right)
WASHINGTON — On Tuesday, at the invitation of U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra, Director of the Domestic Policy Council of the United States Neera Tanden, and Administrator of the Centers for Medicare & Medicaid Services Chiquita Brooks-LaSure held a roundtable at the White House with pharmacy chain and association leaders to discuss how pharmacies can work together with the Biden-Harris Administration to educate consumers about the new Medicare prescription drug benefits under the Inflation Reduction Act.
NACDS President and CEO Steven C. Anderson (left) and NACDS Vice Chair Kevin Host, senior vice president of Pharmacy, Walmart (right), at the July 18 roundtable held at the White House to discuss the Inflation Reduction Act.
NACDS and NACDS member representatives including Rite Aid, Walgreens and Walmart engaged in a discussion at the White House on the implementation of the Inflation Reduction Act (IRA) — and “how pharmacies can work together to build on the progress made under President Biden’s [IRA] to further bring down the cost of prescription drugs and educate consumers about the benefits of the law.”
Through the engagement of the membership, NACDS brought its pro-patient and pro-pharmacy perspective to the IRA during its Congressional consideration and continues to shape the IRA during its implementation.
